Insight

Stacie Lindsey: Join the 2024 Houston Cholangiocarcinoma Symposium

Stacie Lindsey/X

Oct 30, 2024, 13:37

Stacie Lindsey: Join the 2024 Houston Cholangiocarcinoma Symposium

Stacie Lindsey, CEO at Cholangiocarcinoma Foundation, shared a post on LinkedIn:

“Please join the Cholangiocarcinoma Foundation for the 2024 Houston Cholangiocarcinoma Symposium on December 13 at MD Anderson Cancer Center.

This symposium is a great platform for patients, caregivers, and healthcare providers to learn about latest advancements in cholangiocarcinoma research and treatment.

Don’t miss the opportunity to be part of this important conversation and get your questions answered. Translation services will be available.

Stacie Lindsey

cancer Cholangiocarcinoma Foundation cholangiocarcinoma research cholangiocarcinoma treatment Houston Cholangiocarcinoma Symposium MD Anderson Cancer Center OncoDaily Oncology Stacie Lindsey

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage